Anika Therapeutics (ANIK) Competitors $11.68 -0.03 (-0.26%) As of 12:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. CERS, OSUR, UTMD, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Cerus OraSure Technologies Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Anika Therapeutics (NASDAQ:ANIK) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Does the MarketBeat Community believe in ANIK or CERS? Cerus received 262 more outperform votes than Anika Therapeutics when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 64.57% of users gave Anika Therapeutics an outperform vote. CompanyUnderperformOutperformAnika TherapeuticsOutperform Votes30864.57% Underperform Votes16935.43% CerusOutperform Votes57072.34% Underperform Votes21827.66% Do institutionals & insiders hold more shares of ANIK or CERS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 7.9% of Anika Therapeutics shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to ANIK or CERS? In the previous week, Anika Therapeutics and Anika Therapeutics both had 2 articles in the media. Cerus' average media sentiment score of 0.84 beat Anika Therapeutics' score of 0.82 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, ANIK or CERS? Cerus has higher revenue and earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$117.05M1.43-$82.67M-$3.88-3.01Cerus$185.14M1.30-$37.49M-$0.10-12.55 Do analysts prefer ANIK or CERS? Anika Therapeutics currently has a consensus target price of $21.33, suggesting a potential upside of 82.65%. Cerus has a consensus target price of $3.50, suggesting a potential upside of 178.88%. Given Cerus' higher possible upside, analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ANIK or CERS more profitable? Cerus has a net margin of -11.60% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-59.40% -2.22% -1.75% Cerus -11.60%-40.55%-11.12% Which has more volatility and risk, ANIK or CERS? Anika Therapeutics has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. SummaryCerus beats Anika Therapeutics on 10 of the 17 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.14M$4.43B$5.32B$8.44BDividend YieldN/A43.63%5.21%4.11%P/E Ratio-1.7529.3226.8119.78Price / Sales1.4365.71387.95118.50Price / Cash3.5351.0838.2534.62Price / Book0.816.206.774.52Net Income-$82.67M$67.60M$3.23B$248.32M7 Day Performance-4.58%-0.57%1.73%0.58%1 Month Performance-17.69%18.14%10.92%13.09%1 Year Performance-54.03%21.28%17.16%7.74% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.0509 of 5 stars$11.68-0.3%$21.33+82.6%-54.5%$167.14M$117.05M-1.75300CERSCerus2.8919 of 5 stars$1.35+4.7%$3.50+159.3%-32.4%$258.07M$185.14M-12.27290Positive NewsGap UpOSUROraSure Technologies4.0307 of 5 stars$2.67+6.4%$5.50+106.0%-48.0%$206.89M$185.83M17.80840Analyst ForecastUTMDUtah Medical Products2.1548 of 5 stars$54.02+0.8%N/A-22.4%$177.29M$39.27M13.68180Positive NewsDividend AnnouncementCOOCooper Companies3.1372 of 5 stars$84.44+2.6%$110.25+30.6%-18.0%$16.89B$3.93B43.3014,000Positive NewsUpcoming EarningsAnalyst UpgradeWSTWest Pharmaceutical Services4.5741 of 5 stars$219.20+2.9%$332.50+51.7%-38.0%$15.75B$2.90B32.7710,700Trending NewsAnalyst RevisionALGNAlign Technology4.7796 of 5 stars$189.00+3.9%$241.25+27.6%-34.9%$13.84B$3.98B33.6923,200Positive NewsMMSIMerit Medical Systems4.1554 of 5 stars$98.73+3.0%$107.78+9.2%+17.2%$5.83B$1.39B48.406,850Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionICUIICU Medical4.7576 of 5 stars$144.34+4.4%$192.67+33.5%+27.3%$3.55B$2.38B-31.5814,500Insider TradeGap UpHAEHaemonetics4.3178 of 5 stars$70.23+3.0%$97.89+39.4%-28.2%$3.53B$1.36B27.652,820Analyst ForecastGap UpXRAYDENTSPLY SIRONA4.953 of 5 stars$16.75+5.9%$20.36+21.6%-43.9%$3.34B$3.72B-8.0915,000 Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Cooper Companies Alternatives West Pharmaceutical Services Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives Haemonetics Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIK Stock Free ANIK Stock Alerts